Paper6091996
Factors affecting spontaneous tumor incidence rates in mice: a literature review.
Everett R. Crit Rev Toxicol, 1984. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Factors affecting spontaneous tumor incidence rates in mice: a literature review. Papers, record 6091996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6091996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mice | Major topic |
| Neoplasms | Major topic |
| Rodent Diseases | Major topic |
| Altitude | |
| Animal Husbandry | |
| Animals | |
| Diet | |
| Dietary Fats | |
| Dietary Proteins | |
| Energy Intake | |
| Female | |
| Germ-Free Life | |
| Leukemia | |
| Lung Neoplasms | |
| Male | |
| Mammary Neoplasms, Experimental | |
| Mammary Tumor Virus, Mouse | |
| Species Specificity | |
| Stress, Physiological |
Source PubMed
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40867321 | Spontaneous Mesotheliomas in Germline Bap1 Heterozygous Mice from Different Genetic Backgrounds. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40867321 | PubMed |
| 18264678 | Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assay. | Invest New Drugs | 2008 | https://conductscience.org/library/papers/18264678 | PubMed |
| 11673124 | Diethylnitrosamine causes pituitary damage, disturbs hormone levels, and reduces sexual dimorphism of certain liver functions in the rat. | Environ Health Perspect | 2001 | https://conductscience.org/library/papers/11673124 | PubMed |
| 9539006 | In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals. | Environ Health Perspect | 1998 | https://conductscience.org/library/papers/9539006 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6091996
GET https://conductscience.org/api/papers/v1/6091996/authors